Winston Medical Supply Co., Ltd.

Winston Medical Supply Co., Ltd.

6817 · TWO · Healthcare / Drug Manufacturers - Specialty & Generic

37.45TWD-1.10 (-2.85%)

Price History

Full chart

Market Stats

Previous Close38.55
Open37.00
Day Range36.80 – 37.45
52-Week Range40.15 – 104.49
Volume29.70K
Market Cap868.36M
P/E (TTM)10.52
Forward P/E0.00
EPS4.48
Dividend Yield10.60%
Beta0.14
50-Day Avg47.07
200-Day Avg65.76

About

Winston Medical Supply Co., Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, chewables, and capsules for the treatment of colds, gastrointestinal issues, and other indications. It also offers medical equipment, medical beauty products, and health food. In addition, the company engages in import and export trade; and manufacturers' agency and bidding business activities. The company was founded in 1974 and is based in Tainan City, Taiwan. Winston Medical Supply Co., Ltd. is a subsidiary of Medigen Biotechnology Corp.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. You-Zheng Wang
  • HeadquartersNo. 117, Ren'ai St., Tainan City, Taiwan, 710, Taiwan
  • Websitehttps://www.winston.com.tw

Leadership

  • Mr. You-Zheng WangGM & Director
  • Ms. Xinwen ZhangAccounting Supervisor & Assistant of Finance Department

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue364.89M505.12M536.53M606.52M709.07M695.08M700.07M
Growth (%)-+38.43%+6.22%+13.05%+16.91%-1.97%+0.72%
Cost of Revenue261.47M301.30M299.13M342.07M361.48M379.24M396.31M
Gross Profit103.42M203.82M237.39M264.45M347.60M315.84M303.77M
Gross Margin28.34%40.35%44.25%43.60%49.02%45.44%43.39%
Operating Expense111.68M120.10M122.11M128.59M151.50M156.59M161.94M
Operating Income-8.25M83.72M115.28M135.86M196.10M159.25M141.82M
Operating Margin-2.26%16.57%21.49%22.40%27.66%22.91%20.26%
EBITDA30.60M125.02M154.55M178.75M228.32M195.00M174.13M
EBITDA Margin8.39%24.75%28.81%29.47%32.20%28.05%24.87%
Net Income-9.36M99.69M92.13M111.26M158.75M131.59M117.29M
Net Income Margin-2.56%19.73%17.17%18.34%22.39%18.93%16.75%
R&D12.31M6.30M7.72M7.00M8.64M9.43M8.76M
R&D as % of Total Revenue3.37%1.25%1.44%1.15%1.22%1.36%1.25%
Interest Expense4.34M3.11M1.84M1.06M1.53M1.17M1.19M
Interest Expense % of Total Revenue1.19%0.62%0.34%0.17%0.22%0.17%0.17%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets614.16M658.87M636.41M701.43M801.78M812.67M780.92M
Total Liabilities441.37M375.35M311.13M339.76M373.88M373.29M353.35M
Total Equity172.79M283.52M325.28M361.67M427.90M439.38M427.57M
Cash132.40M146.34M162.80M202.67M299.14M299.55M298.92M
Total Debt241.98M177.25M104.55M94.41M107.33M103.00M-
Net Debt109.58M30.90M-58.25M-108.26M-191.81M-196.55M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow49.76M111.75M146.46M124.88M215.45M148.09M154.97M
Investing Cash Flow-1.11M544.00K-6.10M-8.62M-19.88M-18.26M-
Financing Cash Flow-33.37M-87.48M-123.90M-76.39M-99.10M-129.41M-
Capital Expenditure6.46M3.20M5.14M6.55M20.04M19.27M17.26M
Free Cash Flow43.29M108.55M141.32M118.33M195.41M128.81M137.71M
Dividends Paid--55.25M73.67M92.08M121.55M128.92M
FCF to OCF87.01%97.14%96.49%94.75%90.70%86.99%88.86%
Dividend Paid to FCF--39.10%62.25%47.12%94.36%93.62%

Key Statistics & Ratios

Market Cap868.36M
Enterprise Value542.95M
Trailing P/E10.52
Forward P/E0.00
Price / Sales1.37
Price / Book2.17
EPS4.48
Book Value19.94
Revenue (TTM)632.80M
Gross Profit (TTM)254.45M
EBITDA119.93M
Profit Margin13.03%
Operating Margin12.75%
Return on Equity22.17%
Return on Assets7.45%
Shares Outstanding18.42M
Shares Float7.53M
Beta0.14
Dividend Yield10.60%
Dividend Rate5.00
Payout Ratio111.64%

Dividends

20261×
5.00Jun 16, 2026
20251×
7.00Jun 13, 2025
20241×
6.60Jun 25, 2024
20231×
5.00Jul 6, 2023
20221×
4.00Jul 21, 2022
20211×
3.00Aug 23, 2021